Mark DeLong - Jan 28, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Senior Vice President
Signature
/s/ David Watson, attorney-in-fact for Mark Delong
Stock symbol
APLS
Transactions as of
Jan 28, 2022
Transactions value $
-$16,748
Form type
4
Date filed
2/1/2022, 05:10 PM
Previous filing
Feb 7, 2022
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$16.7K -434 -2.07% $38.59 20.5K Jan 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.